Correlation Between Microsoft Corp and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft Corp and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft Corp and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft Corp and Immunoprecise Antibodies, you can compare the effects of market volatilities on Microsoft Corp and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft Corp with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft Corp and Immunoprecise Antibodies.

Diversification Opportunities for Microsoft Corp and Immunoprecise Antibodies

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Microsoft and Immunoprecise is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft Corp and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Microsoft Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft Corp are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Microsoft Corp i.e., Microsoft Corp and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Microsoft Corp and Immunoprecise Antibodies

Given the investment horizon of 90 days Microsoft Corp is expected to generate 17.76 times less return on investment than Immunoprecise Antibodies. But when comparing it to its historical volatility, Microsoft Corp is 13.16 times less risky than Immunoprecise Antibodies. It trades about 0.04 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  101.00  in Immunoprecise Antibodies on April 3, 2022 and sell it today you would earn a total of  283.00  from holding Immunoprecise Antibodies or generate 280.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Microsoft Corp  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Microsoft Corp 
Microsoft Performance
0 of 100
Over the last 90 days Microsoft Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in August 2022. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Structure and Payout Changes

Forward Annual Dividend Yield
0.0096
Payout Ratio
0.26
Last Split Factor
2:1
Forward Annual Dividend Rate
2.48
Dividend Date
2022-06-09
Ex Dividend Date
2022-08-17
Last Split Date
2003-02-18

Microsoft Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite sluggish performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in August 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Structure and Payout Changes

Last Split Factor
1:5
Dividend Date
2020-11-23
Last Split Date
2020-11-23

Immunoprecise Price Channel

Microsoft Corp and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Microsoft Corp and Immunoprecise Antibodies

The main advantage of trading using opposite Microsoft Corp and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft Corp position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.
The idea behind Microsoft Corp and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go